As-needed treatment with ranibizumab 0.5 mg in patients with neovascular age-related macular degeneration. (FALTA) 26/03/2013
Dry or atrophic AMDExudative or wet AMDIndocyanine green angiographyAutofluorescenceMicroperimetryFluorescein angiographyOptical coherence tomographyRetina scan
01/01/2015FOVISTA: Clinical Trial for subfoveal neovascular age-related macular degeneration
19/03/2014Clinical trial in antiretroviral-naive patients with choroidal neovascularization secondary to AMD
31/03/2014Phase III Study of Lampalizumab in patients with geographic atrophy secondary to AMD
20/12/2014MPL4 GA: A phase I study in subjects with geographic atrophy secondary to dry age-related macular degeneration
